Thomas Campbell Article on SCOTUS and the Scope of Enablement in Amgen v. Sanofi Published in IPWatchdog

Intellectual Property partner Thomas J. Campbell, Jr., recently authored the article “SCOTUS Takes on Scope of Enablement Inquiry in Amgen v. Sanofi: Implications for Pharma/ Biotech and Beyond,” published in IPWatchdog on November 13. In the article, Tom explains how the Supreme Court will take up a case asking the court to weigh in on whether the quality or quantity of experimentation dictates whether an invention is sufficiently enabled.

Click here to read the article.